small molecule

TROSPIUM CHLORIDE

TROSPIUM CHLORIDE

Loss of exclusivityloss of exclusivity
CompanyPADAGIS US LLC

Drug detail

Brand nameTROSPIUM CHLORIDE
Active ingredientTROSPIUM CHLORIDE
Strength60MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2013
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TROSPIUM CHLORIDE patent cliff — loss of exclusivity — | CliffBio